Revance Therapeutics, Inc.
RVNCDelisted Feb 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479290
Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.
Politicians who traded RVNC
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 1
- Filings
- 1
- Politicians
- 1
- Buys / sells
- 1 / 0
- Estimated volume
- $8.00K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Thomas R. Carper Senate · DE | 1 | 1 / 0 | $8.00K | Oct 4, 2023 | Nov 2, 2023 |
Trades
Reported trades in Revance Therapeutics, Inc., newest filings first.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.